Professor Andrea Necchi is a medical oncologist specialized in the treatment of urological malignancies. He received his medical degree at the University of Milan, Italy, and subsequently he completed the post-doc specialization in medical oncology at the same University. Prof. Necchi’s activity is fully dedicated to the treatment of genitourinary malignancies. Since his clinical training as a medical student, he worked at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
In November 2020 he was appointed associate professor of oncology at Vita-Salute San Raffaele University and Director of Genitourinary Medical Oncology at IRCCS San Raffaele Hospital and Scientific Institute in Milan, Italy. His research team is focused on the entire spectrum of urological malignancies and is primarily devoted to the development of all-phases clinical trials with new experimental therapies. In particular, the most relevant interest in his recent work was focused on the development of perioperative strategies aimed at delivering new therapies combined with radical surgery in early-stage, operable disease.
He currently serves as a board member of the EAU Research Foundation, and he is associate member of the ASCO-EAU penile cancer guidelines panel.
He is principal investigator of several academic phase 1-2 trials of immuno-oncology combinations in urological malignancies.
Prof. Necchi has been the first recipient of the “Gianni Bonadonna prize for new drug development in Oncology” and earned four Merit Awards from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO).